A rapid genetic testing model for patients with advanced prostate cancer can more quickly identify those with "actionable" gene variants eligible for newer targeted therapies, reports a clinical trial ...

From 7% to nearly 9% of patients with advanced cancer were found to harbor a germline variant with targeted therapeutic actionability in the first study of its kind. The study involved 11,974 patients ...

Only 35% of advanced cancer patients received comprehensive genomic profiling testing. Tested patients were more likely to receive targeted therapies. Testing rates increased slightly over time and ...

In a healthcare environment shaped by protocols and time constraints, many people often experience long journeys marked by inconclusive answers and persistent symptoms. Dr. Jeffrey L. Brown, founder ...

"Clinicians performing tumor biopsy need to ensure that there’s adequate tissue for both diagnosis and NGS testing. Having immediate pathology review of biopsy specimens in the operating room can ...

CAMBRIDGE, England--(BUSINESS WIRE)--A new, highly accurate testing service that improves the early-stage detection of bowel cancer with strong clinical validity will be available in the UK within the ...

Materials testing is critical in product development and manufacturing across various industries. It ensures that products can withstand tough conditions in their ...

The Donald Trump administration is reportedly urging Meta Platforms, Inc. META to allow federal officials to review its advanced artificial intelligence models before they are released. Trump ...

With developments in drone technology, the need for counter-UAV systems has been rapidly increasing as well. With many private and public sector sites installing systems to prevent drones in the ...